CVS Health Corporation (CVS) Shares Bought by ARGI Investment Services LLC

ARGI Investment Services LLC grew its stake in shares of CVS Health Corporation (NYSE:CVS) by 5.9% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,807 shares of the pharmacy operator’s stock after acquiring an additional 659 shares during the period. ARGI Investment Services LLC’s holdings in CVS Health Corporation were worth $927,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Newman Dignan & Sheerar Inc. grew its holdings in shares of CVS Health Corporation by 0.7% during the 2nd quarter. Newman Dignan & Sheerar Inc. now owns 30,560 shares of the pharmacy operator’s stock valued at $2,459,000 after acquiring an additional 198 shares in the last quarter. Atwood & Palmer Inc. grew its holdings in shares of CVS Health Corporation by 4.0% during the 2nd quarter. Atwood & Palmer Inc. now owns 202,360 shares of the pharmacy operator’s stock valued at $16,282,000 after acquiring an additional 7,774 shares in the last quarter. Cim Investment Mangement Inc. grew its holdings in shares of CVS Health Corporation by 96.5% during the 2nd quarter. Cim Investment Mangement Inc. now owns 15,840 shares of the pharmacy operator’s stock valued at $1,274,000 after acquiring an additional 7,777 shares in the last quarter. Boston Research & Management Inc. grew its holdings in shares of CVS Health Corporation by 1.5% during the 2nd quarter. Boston Research & Management Inc. now owns 35,187 shares of the pharmacy operator’s stock valued at $2,831,000 after acquiring an additional 520 shares in the last quarter. Finally, Crawford Investment Counsel Inc. grew its holdings in shares of CVS Health Corporation by 6.8% during the 2nd quarter. Crawford Investment Counsel Inc. now owns 687,232 shares of the pharmacy operator’s stock valued at $55,295,000 after acquiring an additional 43,615 shares in the last quarter. Institutional investors and hedge funds own 81.46% of the company’s stock.

CVS Health Corporation (NYSE:CVS) opened at $70.99 on Friday. The company has a market cap of $71,912.30, a PE ratio of 12.43, a PEG ratio of 1.22 and a beta of 0.86. The company has a current ratio of 1.05, a quick ratio of 0.56 and a debt-to-equity ratio of 0.67. CVS Health Corporation has a 52-week low of $66.45 and a 52-week high of $84.72.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.01. The business had revenue of $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. CVS Health Corporation had a net margin of 2.77% and a return on equity of 16.96%. The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.64 earnings per share. sell-side analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 3rd. Stockholders of record on Tuesday, October 24th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.82%. The ex-dividend date of this dividend was Monday, October 23rd. CVS Health Corporation’s dividend payout ratio is currently 41.32%.

WARNING: This news story was originally published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this news story on another site, it was illegally copied and reposted in violation of US & international copyright and trademark law. The correct version of this news story can be accessed at https://www.chaffeybreeze.com/2017/11/12/cvs-health-corporation-cvs-shares-bought-by-argi-investment-services-llc.html.

In other news, EVP Thomas M. Moriarty sold 20,547 shares of the company’s stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the completion of the transaction, the executive vice president now owns 43,178 shares of the company’s stock, valued at $3,504,758.26. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO David M. Denton sold 237,078 shares of the company’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $79.65, for a total transaction of $18,883,262.70. Following the transaction, the chief financial officer now directly owns 141,096 shares of the company’s stock, valued at approximately $11,238,296.40. The disclosure for this sale can be found here. Insiders have sold 716,625 shares of company stock valued at $58,318,431 in the last ninety days. 0.61% of the stock is owned by company insiders.

Several equities analysts have recently commented on the stock. BidaskClub upgraded shares of CVS Health Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, August 2nd. Citigroup Inc. lowered their price target on shares of CVS Health Corporation from $88.00 to $87.00 and set a “neutral” rating on the stock in a report on Thursday, August 17th. Royal Bank of Canada assumed coverage on shares of CVS Health Corporation in a report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price target on the stock. Jefferies Group LLC boosted their price target on shares of CVS Health Corporation from $82.00 to $86.00 and gave the company a “hold” rating in a report on Friday, September 15th. Finally, Wolfe Research cut shares of CVS Health Corporation from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from $89.00 to $82.00 in a report on Monday, August 14th. One analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $85.82.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply